Showing 6881-6900 of 7110 for: Cochrane Systematic Reviews Back
- Vaccines for preventing anthrax
Cochrane Systematic Reviews, 5-Feb-2009
Anthrax is a bacterial zoonosis that occasionally causes human disease and is potentially fatal. Anthrax vaccines include a live-attenuated vaccine, an alum-precipitated cell-free filtrate vaccine, and a recombinant protein vaccine.
- Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected)
Cochrane Systematic Reviews, 1-Sep-2010
Injected cholera vaccines are rarely used today, although they may have some benefit. It is valuable to summarize the evidence for effectiveness of injected cholera vaccines for comparison with newer oral vaccines (subject of a separate Cochrane Review).
- Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea
Cochrane Systematic Reviews, 28-Jun-2013
Infection with enterotoxigenic Escherichia coli (ETEC) bacteria is a common cause of diarrhoea in adults and children in developing countries and is a major cause of 'travellers' diarrhoea' in people visiting or returning from endemic regions. A killed wh
- Vaccines for preventing hepatitis B in health-care workers
Cochrane Systematic Reviews, 15-Oct-2008
Hepatitis B virus (HBV) causes acute and chronic liver diseases. Hepatitis B vaccination is recommended for health-care workers.
- Vaccines for preventing herpes zoster in older adults
Cochrane Systematic Reviews, 2-Mar-2016
Herpes zoster, also known as 'shingles', is a neurocutaneous disease characterised by the reactivation of the latent varicella zoster virus (VZV), the virus that causes chickenpox when immunity to VZV declines. It is an extremely painful condition that ca
- Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis
Cochrane Systematic Reviews, 17-Aug-2015
Chronic pulmonary infection in cystic fibrosis results in progressive lung damage. Once colonisation of the lungs with Pseudomonas aeruginosa occurs, it is almost impossible to eradicate. Vaccines, aimed at reducing infection with Pseudomonas aeruginosa,
- Vaccines for preventing influenza in healthy adults
Cochrane Systematic Reviews, 4-Mar-2014
Different types of influenza vaccines are currently produced worldwide. Vaccination of pregnant women is recommended internationally, while healthy adults are targeted in North America.
- Vaccines for preventing influenza in healthy children
Cochrane Systematic Reviews, 3-Sep-2014
The consequences of influenza in children and adults are mainly absenteeism from school and work. However, the risk of complications is greatest in children and people over 65 years of age.
- Vaccines for preventing influenza in people with asthma
Cochrane Systematic Reviews, 19-Dec-2012
Influenza vaccination is recommended for asthmatic patients in many countries as observational studies have shown that influenza infection can be associated with asthma exacerbations. However, influenza vaccination has the potential to cause wheezing and
- Vaccines for preventing influenza in people with cystic fibrosis
Cochrane Systematic Reviews, 12-Feb-2014
Viral respiratory tract infections in people with cystic fibrosis have a deteriorating effect on their lung function and disease progression. Annual influenza vaccination is therefore commonly recommended for people with cystic fibrosis.
- Vaccines for preventing influenza in the elderly
Cochrane Systematic Reviews, 1-Feb-2018
The consequences of influenza in the elderly (those age 65 years or older) are complications, hospitalisations, and death. The primary goal of influenza vaccination in the elderly is to reduce the risk of death among people who are most vulnerable. This i
- Vaccines for preventing invasive salmonella infections in people with sickle cell disease
Cochrane Systematic Reviews, 8-May-2015
Salmonella infections are a common bacterial cause of invasive disease in people with sickle cell disease especially children, and are associated with high morbidity and mortality rates. Although available in some centres, people with sickle cell anaemia
- Vaccines for preventing Japanese encephalitis
Cochrane Systematic Reviews, 9-Nov-2008
Vaccination is recognized as the only practical measure for preventing Japanese encephalitis. Production shortage, costs, and issues of licensure impair vaccination programmes in many affected countries. Concerns over vaccine effectiveness and safety also
- Vaccines for preventing malaria
Cochrane Systematic Reviews, 11-Nov-2008
Four types of malaria vaccine, SPf66 and MSP/RESA vaccines (against the asexual stages of the Plasmodium parasite) and CS-NANP and RTS,S vaccines (against the sporozoite stages), have been tested in randomized controlled trials in endemic areas.
- Vaccines for preventing malaria (blood-stage)
Cochrane Systematic Reviews, 9-Nov-2008
A malaria vaccine is needed because of the heavy burden of mortality and morbidity due to this disease. This review describes the results of trials of blood (asexual)-stage vaccines. Several are under development, but only one (MSP/RESA, also known as Com
- Vaccines for preventing malaria (pre-erythrocytic)
Cochrane Systematic Reviews, 9-Nov-2008
Vaccines against all stages of the malaria parasite are in development, mainly for Plasmodium falciparum, which causes the most serious form of malaria. Pre-erythrocytic vaccines act to prevent or delay a malaria attack by attacking the sporozoite and liv
- Vaccines for preventing malaria (SPf66)
Cochrane Systematic Reviews, 17-Feb-2009
A malaria vaccine is badly needed. SPf66 was one of the earliest vaccines developed. It is a synthetic peptide vaccine containing antigens from the blood stages of malaria linked together with an antigen from the sporozoite stage, and is targeted mainly a
- Vaccines for preventing plague
Cochrane Systematic Reviews, 10-Jan-2012
Plague is endemic in China, Mongolia, Burma, Vietnam, Indonesia, India, large parts of Southern Africa, the United States and South America. There are three types of vaccines (live attenuated, killed and F1 fraction) with varying means of administration.
- Vaccines for preventing pneumococcal infection in adults
Cochrane Systematic Reviews, 19-Nov-2012
Diseases caused by Streptococcus pneumoniae (S. pneumoniae) continue to cause substantial morbidity and mortality globally. Whilst pneumococcal polysaccharide vaccines (PPVs) have the potential to prevent disease and death, the degree of protection afford
- Vaccines for preventing rotavirus diarrhoea: vaccines in use
Cochrane Systematic Reviews, 17-Nov-2021
Rotavirus is a common cause of diarrhoea, diarrhoea-related hospital admissions, and diarrhoea-related deaths worldwide. Rotavirus vaccines prequalified by the World Health Organization (WHO) include Rotarix (GlaxoSmithKline), RotaTeq (Merck), and, more r